In addition, NHS Quality Improvement Scotland is developing proposals to consider the feasibility of a national reporting approach for adverse events, building on the arrangements currently in place across all NHS boards in Scotland. In relation to the safety of medicines available on the UK market, the Medicines and Healthcare products Regulatory Agency and the Commission on Human Medicines run the UK''s spontaneous adverse drug reaction reporting scheme, the Yellow Card Scheme.